National Bank of Canada’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
66,952
+4,353
| +7% | +$167K | ﹤0.01% | 881 |
|
|
2025
Q1 | $2.43M | Sell |
62,599
-1,766
| -3% | -$68.4K | ﹤0.01% | 847 |
|
|
2024
Q4 | $2.18M | Sell |
64,365
-2,709
| -4% | -$91.6K | ﹤0.01% | 907 |
|
|
2024
Q3 | $2.74M | Sell |
67,074
-7,259
| -10% | -$297K | ﹤0.01% | 820 |
|
|
2024
Q2 | $2.85M | Sell |
74,333
-672
| -0.9% | -$25.7K | ﹤0.01% | 776 |
|
|
2024
Q1 | $3.38M | Buy |
75,005
+2,602
| +4% | +$117K | 0.01% | 774 |
|
|
2023
Q4 | $2.72M | Sell |
72,403
-107,220
| -60% | -$4.02M | ﹤0.01% | 818 |
|
|
2023
Q3 | $6.45M | Sell |
179,623
-138,316
| -44% | -$4.97M | 0.01% | 597 |
|
|
2023
Q2 | $11.2M | Sell |
317,939
-83,141
| -21% | -$2.94M | 0.02% | 459 |
|
|
2023
Q1 | $14.4M | Sell |
401,080
-3,475
| -0.9% | -$125K | 0.04% | 297 |
|
|
2022
Q4 | $14.2M | Sell |
404,555
-148,153
| -27% | -$5.2M | 0.04% | 313 |
|
|
2022
Q3 | $16.6M | Sell |
552,708
-14,503
| -3% | -$436K | 0.09% | 232 |
|
|
2022
Q2 | $31M | Buy |
567,211
+41,775
| +8% | +$2.28M | 0.14% | 130 |
|
|
2022
Q1 | $29.6M | Buy |
525,436
+354,239
| +207% | +$20M | 0.09% | 160 |
|
|
2021
Q4 | $9.44M | Buy |
+171,197
| New | +$9.44M | 0.03% | 342 |
|